---
figid: PMC11011422__ijms-25-03896-g005
pmcid: PMC11011422
image_filename: ijms-25-03896-g005.jpg
figure_link: /pmc/articles/PMC11011422/figure/ijms-25-03896-f005/
number: Figure 5
figure_title: ''
caption: Engineered bacteria harboring a shRNA plasmid targeting indoleamine 2,3-dioxygenase
  (IDO) can activate the CTNNB1 pathway and induce colorectal carcinogenesis, with
  the shRNA employing bacteria as a vector to transport therapeutic RNAi target cells
  to silence specific mRNAs.
article_title: A Review of the Use of Native and Engineered Probiotics for Colorectal
  Cancer Therapy.
citation: Huawen Han, et al. Int J Mol Sci. 2024 Apr;25(7):3896.
year: '2024'

doi: 10.3390/ijms25073896
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- colorectal cancer
- synthetic biology
- probiotics and engineered strain

---
